Compare XPH and IDNA | ETF Tracker

XPH and IDNA, Ranked

Today

FundFeeYieldYTD1 year3 yrs · yr5 yrs · yrWorst dropVolatilityAssetsAvg rank

iShares Genomics Immunology and Healthcare ETFSectors · Health care0.47%0.64%+67.1%+76.1%+34.3%−2.0%−10.6%30.7%$363M1.4

State Street SPDR S&P Pharmaceuticals ETFSectors · Health care0.35%0.41%+20.6%+39.3%+24.1%+8.0%−16.5%24.5%$477M1.6

Rank among the two1st → 2ndFee, drop and volatility: lower ranks higherAvg rank: mean of the 8 ranks · 1 is best

End-of-day Nov 9, 2026 · returns include dividends · since: XPH 2006 · IDNA 2019

Head to Head

Swap sides Versus in desk

Head to Head

5Y

State Street SPDR S&P Pharmaceuticals ETF · $477M$14,671

XPH

IDNA

iShares Genomics Immunology and Healthcare ETF · $363M$9,047

$10,000 five years ago, dividends reinvested · they hold 3.0% in common

XPHMeasureIDNA

+20.6%Year to dateJan 1 → Nov 9+67.1%

+39.3%1 yearTotal return+76.1%

+24.1%3 years · per year$10,000 became $19,112 · $24,232+34.3%

+8.0%5 years · per year$10,000 became $14,671 · $9,047−2.0%

0.35%Expense ratio$35 · $47 a year on $10k · lower is better0.47%

0.41%Trailing 12-mo yield$41 · $64 a year on $10k0.64%

−16.5%Worst dropSmaller is better−10.6%

24.5%VolatilityLower is calmer30.7%

XPHIDNA Winner of the row, in its colourEach row: the bigger of the two fills its side

3–5IDNA wins

End-of-day Nov 9, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns

More Ways to See the Pairs

XPH vs IDNA: Top 5 Holdings

Today

XPH

14.9%in top 5

IDNA

in top 533.8%

XPHStockIDNA

not top 5MRNA14.9%

not top 5GMAB.CO5.9%

not top 5TWST4.9%

4.1%XERSnot top 5

not top 5BAYN.DE4.1%

not top 5REGN4.0%

2.9%MANEnot top 5

2.7%PCRXnot top 5

2.6%MAZEnot top 5

2.5%VTRSnot top 5

Held in common3.0%

End-of-day Nov 9, 2026 · share of each fund

XPH vs IDNA Returns, Every Period

5Y

SPDRXPH

+8.0%

5 years, per year

IDNAiShares

−2.0%

5 years, per year

XPHIDNAFaded: behind in that period

1–3IDNA wins

End-of-day Nov 9, 2026 · dividends in · faded = behind in that period

XPH vs IDNA

YTD

SPDRXPH

+20.6%

IDNAiShares

+67.1%

+20.6%Year to date+67.1%

−16.5%Worst drop · 1Y−10.6%

24.5%Volatility · 1Y30.7%

0.4%Yield0.6%

$477MAssets$363M

3–1IDNA wins

End-of-day Nov 9, 2026 · smaller drop and lower volatility win

Cost, Income and Risk

Fees: XPH, IDNA

Today

0.35%lowest, XPH

FundExpense ratioFee$10k

XPH0.35%$35

IDNA0.47%$47

End-of-day Nov 9, 2026 · fee on $10,000 a year

Yields: XPH, IDNA

1Y

0.64%highest, IDNA

FundTrailing yieldYield$10k

IDNA0.64%$64

XPH0.41%$41

End-of-day Nov 9, 2026 · trailing 12-month yield

Income After Fees on $10,000

1Y

$17most kept, IDNA

IDNA$64 − $47 = $17

XPH$41 − $35 = $6

KeptFee

End-of-day Nov 9, 2026 · yield in dollars minus the fee

Overlap: XPH, IDNA

Today

3.0%most shared, XPH and IDNA

XPHIDNA

XPH—3.0%

IDNA3.0%—

End-of-day Nov 9, 2026 · share held in common · outlined: the pair in versus

Return vs Bumpiness: 2 ETFs

1Y

+76.1%IDNA, at 30.7% volatility

XPHWorst drop−16.5%24.5% vol

IDNAWorst drop−10.6%30.7% vol

End-of-day Nov 9, 2026 · up and left is better

Paid More vs Made More

YTD

IDNAXPH

+67.1%Year to date+20.6%

0.6%Yield0.4%

+76.1%Past year+39.3%

0.47%Fee0.35%

3–1IDNA wins

End-of-day Nov 9, 2026

Popular Pairs Near These Two

SCHD vs VIG

YTD

SchwabSCHD

+33.2%

VIGVanguard

+14.8%

+33.2%Year to date+14.8%

3.0%Yield1.5%

$122BAssets$109B

2–0SCHD wins

End-of-day Nov 9, 2026

JEPQ vs JEPI

YTD

J.P. MorganJEPQ

+6.6%

JEPIJ.P. Morgan

+7.5%

+6.6%Year to date+7.5%

12.4%Yield7.9%

$40.7BAssets$45.2B

1–1level

End-of-day Nov 9, 2026

SPYM vs SPY

YTD

SPDRSPYM

+11.3%

SPYSPDR

+11.2%

+11.3%Year to date+11.2%

1.0%Yield1.0%

$179BAssets$778B

1–0SPYM wins

End-of-day Nov 9, 2026